Treatment Strategy for Recurrent and Refractory Epithelial Ovarian Cancer: Efficacy of High-Dose Chemotherapy with Hematopoietic Stem Cell Transplantation-Reference-Cited by-同舟云学术

Treatment Strategy for Recurrent and Refractory Epithelial Ovarian Cancer: Efficacy of High-Dose Chemotherapy with Hematopoietic Stem Cell Transplantation

Published:2006 Issue:3 Volume:39 Page:61-67
ISSN:0044-5991
Container-title:ACTA HISTOCHEMICA ET CYTOCHEMICA
language:en
Short-container-title:Acta Histochem. Cytochem

Author:

Muramatsu Toshinari¹,Shinozuka Takao²,Hirasawa Takeshi¹,Tsukada Hitomi¹,Maeda Hironobu¹,Miyamoto Tsuyoshi¹,Murakami Masaru¹,Kajiwara Hiroshi³,Yasuda Masanori³,Osamura R. Yoshiyuki³,Mikami Mikio¹

Affiliation:

1. Department of Obstetrics and Gynecology, Tokai University School of Medicine

2. Department of Gynecology, Ayase Kosei Hospital

3. Department of Pathology, Tokai University School of Medicine

Publisher

Japan Society of Histochemistry & Cytochemistry

Subject

Cell Biology,Histology,Physiology,Biochemistry,Pathology and Forensic Medicine

Link

http://www.jstage.jst.go.jp/article/ahc/39/3/39_3_61/_pdf

Reference42 articles.

1. Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials

2. 2. Alberts, D. S., Young, L., Mason, N. and Salmon, S. E. (1985) In vitro evaluation of anticancer drugs against ovarian cancer at concentrations achievable by intraperitoneal administration. Semin. Oncol. 12; 38-42.

3. 4. Balat, O., Kudelka, A. P., Tunca, J. C., Edwards, C. L., Verschraegen, C. and Kavanagh, J. J. (1996) Prolonged stabilization of progressive platinum-refractory ovarian cancer with paclitaxel: brief report. Eur. J. Gynaecol. Oncol. 17; 264-266.

4. Salvage Therapy for Recurrent and Refractory Ovarian Cancer with High-Dose Chemotherapy and Autologous Bone Marrow Support: A Gynecologic Oncology Group Pilot Study

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic effect of haploidentical peripheral blood stem cell treatment on relapsed/refractory ovarian cancer;Bulletin du Cancer;2023-03

2. (E)-2,4-Bis(p-hydroxyphenyl)-2-butenal enhanced TRAIL-induced apoptosis in ovarian cancer cells through downregulation of NF-κB/STAT3 pathway;Archives of Pharmacal Research;2014-01-04

3. Semi-Mechanistic Model for Neutropenia after High Dose of Chemotherapy in Breast Cancer Patients;Pharmaceutical Research;2009-06-02